CD38 inhibitors and methods of treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9840496
SERIAL NO

15529120

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of Formula I and methods of treating diseases of metabolism by modulating cellular NAD+ levels through the inhibition of the CD38 enzyme, are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Becherer, J David Research Triangle Park, US 1 1
Cadilla, Rodolfo King of Prussia, US 29 182
Deaton, David Norman King of Prussia, US 20 181
Haffner, Curt King of Prussia, US 1 1
Henke, Brad Richard Research Triangle Park, US 6 31
Preugschat, Frank Research Triangle Park, US 2 3
Schulte, Christie King of Prussia, US 5 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00